BioInvest

HanAll Biopharma and Daewoong Pharmaceutical Invest in Turn Biotechnologies to Expand Growth Initiative

HanAll Biopharma (KRX: 009420.KS) and Daewoong Pharmaceutical (KRX: 069620.KS) today announced expansion of their open collaboration strategy by investing ...

 April 13, 2022 | News

Daewoong Pharmaceutical and HanAll Biopharma Invest in Turn Biotechnologies to Expand Growth Initiative

Daewoong Pharmaceutical (KRX: 069620.KS) and HanAll Biopharma (KRX: 009420.KS) today announced expansion of their open collaboration strategy by inves...

 April 12, 2022 | News

Mindtree Invests in COPE Health Solutions to Accelerate its Healthcare Business

Based in Los Angeles and New York, COPE Health Solutions works with health systems, health plans, medical groups, and other healthcare organ...

 April 06, 2022 | News

RNAimmune Secures $27 Million Series A Round of Financing for Development of mRNA Therapeutics and Vaccines

The Company intends to use the funding to accelerate its research and development of mRNA vaccine and drug discovery focused on infectious disease, cancer,...

 March 30, 2022 | News

Samsung Biologics holds 11th Annual General Meeting of Shareholders

Five matters were presented and approved unanimously at this year's meeting, which included the approval of financial statement, appointment of directors, ...

 March 29, 2022 | News

Genscript Biotech Reports 2021 Annual Results

Revenue of the Group for the year ended December 31, 2021 was approximately US$511.1 million, representing an increase of 30.8% as compare...

 March 21, 2022 | News

Eppendorf invests in Swiss startup BigOmics

“We’re excited to invest in BigOmics,” said Peter Fruhstorfer, Co-CEO of Eppendorf SE, upon signing the agreement. “With its expert...

 March 15, 2022 | News

MediLink Therapeutics closes US$70 million Series B financing

The new funding will support clinical development of MediLink's new generation Antibody-Drug Conjugate (ADC) pipeline, as well as early discovery and devel...

 March 15, 2022 | News

Biocon Biologics to Acquire Viatris' Biosimilar Assets for Up to US$3.335 Billion in Cash and Equity

Biocon Biologics Ltd., a subsidiary of Biocon Ltd. (BSE: 532523) (NSE: BIOCON), has entered into a definitive agreement with its partner Viatris Inc. (NASD...

 March 03, 2022 | News

MediBuddy Raises USD 125 Million in Series C Funding

MediBuddy, India's largest end-to-end digital healthcare platform, has raised USD 125 million in Series C funding from Quadria Cap...

 February 25, 2022 | News

Molecule partners to develop Web3-based ecosystem addressing inefficiencies in biopharma R&D

VitaDAO and Molecule collaboratively source geroscience assets and finance R&D at universities, institutes, and biotech companies. VitaDAO has a worldw...

 February 22, 2022 | News

Formus Labs Raises $5 Million to Automate Orthopedic Surgery Planning

Formus combines AI and biomechanics to empower orthopedic surgeons with fully interactive 3D models to optimize the preoperative planning process AUCKLAND...

 February 03, 2022 | News

WAPG aims to create highly practical advantages to science start-ups

Today, We are Pioneer Group (WAPG) launches new nationwide partnerships with Leyton, the UK's largest innovation funding consultancy, and leading UK law ...

 January 27, 2022 | News

Venus Medtech Concludes Acquisition of 100% Equity Interest in Cardiovalve

As of today, Cardiovalve becomes a member of the global operation team of Venus Medtech officially, which will accelerate the international footprint of it...

 January 27, 2022 | News


Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close